Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study

Authors:

Abstract
No abstract available
Funding Information
  • Biomedical Advanced Research and Development Authority
  • US Department of Veterans Affairs
  • US Department of Health and Human Services
  • US Food and Drug Administration

This publication has 25 references indexed in Scilit: